Ryplazim Pregnancy Warnings
Animal studies have not been reported. There are no controlled data in human pregnancy.
Safety is unknown, and the manufacturer makes no recommendation regarding use during pregnancy.
US FDA pregnancy category: Not assigned
Risk summary: There are no data available on the use of this drug in pregnant women to inform a drug-related risk.
See references
Ryplazim Breastfeeding Warnings
Safety has not been established. The benefits of breastfeeding should outweigh the risk of potential adverse reactions.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments: Endogenous plasminogen is excreted in human milk; however, the effects of this drug on the nursing infant or milk production are unknown.
See references
